ELAHERE
- Product NDC
- 72903-853
- 11-digit product format
- 729030853
- Labeler code
- 72903
- Product ID
- 72903-853_47f1c78d-c469-4cd7-926e-51ce5b2d26f5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MIRVETUXIMAB SORAVTANSINE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- ImmunoGen, Inc.
- Application
- BLA761310
- Marketing category
- BLA
- Marketing start
- 2022-11-14
- Substance
- MIRVETUXIMAB SORAVTANSINE
- Active strength
- 5 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ELAHERE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MIRVETUXIMAB SORAVTANSINE | 5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 98DE7VN88D |
| Rxcui | 2621553, 2621559 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72903-853-01 | ELAHERE | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 14 |
| 72903-853-01 | ELAHERE | 20 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 20 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72903-853 | ELAHERE (MIRVETUXIMAB SORAVTANSINE) INJECTION, SOLUTION [IMMUNOGEN, INC.] | 11 | Current NDC, Legacy NDC, 2 package rows | 20241101_00c424b5-6ccd-48ab-9e88-1986451120e2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72903-853-01 | 72903085301 | 1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE | 2022-11-14 | 0000-00-00 | No | No | Current |